Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anouk Achten

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Heart Failure Reviews|June 23, 2025
Time to screen: rationale and roadmap for HFpEF screening in individuals with obesityAnouk Achten, Lukas Peeters, Geert Verkoulen, et al.
European Heart Journal. Digital Health|February 6, 2023
Association between phonocardiography and echocardiography in heart failure patients with preserved ejection fractionHongxing Luo, Jerremy Weerts, Anja Bekkers, et al.
ESC Heart Failure|October 27, 2024
Prognostic value of hypoxaemic burden from overnight oximetry in heart failure with preserved ejection fractionSanne G J Mourmans, Jerremy Weerts, Mathias Baumert, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 28, 2025
Prevalence of transthyretin amyloid cardiomyopathy in an unselected cohort with heart failure with preserved ejection fractionAnouk Achten, Vanessa P M van Empel, Jerremy Weerts, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 4, 2025
Sex-specific performance of clinical diagnostic algorithms for HFpEF across two independent cohortsXinyu Li, Anouk Achten, Soufiane Nassiri, et al.
Heart and Vessels|May 6, 2024
Changes in the diagnostic trajectory of transthyretin cardiac amyloidosis over six yearsAnouk Achten, Vanessa P M van Empel, Jerremy Weerts, et al.
European Journal of Preventive Cardiology|July 10, 2025
The diagnostic yield of an elaborate workup for comorbidities in a real-life HFpEF outpatient populationSanne G J Mourmans, Anouk Achten, Jerremy Weerts, et al.
Cardiovascular Diabetology|April 5, 2025
Temporal prevalence and prognostic impact of diabetes mellitus and albuminuria in heart failure with preserved ejection fractionNousjka P A Vranken, Xinyu Li, Heleen Bouman, et al.
Annals of Medicine|October 26, 2024
Diversity of heart failure phenotypes in transthyretin amyloid cardiomyopathy. More than just heart failure with preserved ejection fractionAnouk Achten, Steven A Muller, Sandra Sanders-van Wijk, et al.
Cardiovascular Diabetology|April 25, 2025
The effect of empagliflozin on peripheral microvascular dysfunction in patients with heart failure with preserved ejection fractionSanne G J Mourmans, Anouk Achten, Raquel Hermans, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Heart Failure Reviews|June 23, 2025
Time to screen: rationale and roadmap for HFpEF screening in individuals with obesityAnouk Achten, Lukas Peeters, Geert Verkoulen, et al.
European Heart Journal. Digital Health|February 6, 2023
Association between phonocardiography and echocardiography in heart failure patients with preserved ejection fractionHongxing Luo, Jerremy Weerts, Anja Bekkers, et al.
ESC Heart Failure|October 27, 2024
Prognostic value of hypoxaemic burden from overnight oximetry in heart failure with preserved ejection fractionSanne G J Mourmans, Jerremy Weerts, Mathias Baumert, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 28, 2025
Prevalence of transthyretin amyloid cardiomyopathy in an unselected cohort with heart failure with preserved ejection fractionAnouk Achten, Vanessa P M van Empel, Jerremy Weerts, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 4, 2025
Sex-specific performance of clinical diagnostic algorithms for HFpEF across two independent cohortsXinyu Li, Anouk Achten, Soufiane Nassiri, et al.
Heart and Vessels|May 6, 2024
Changes in the diagnostic trajectory of transthyretin cardiac amyloidosis over six yearsAnouk Achten, Vanessa P M van Empel, Jerremy Weerts, et al.
European Journal of Preventive Cardiology|July 10, 2025
The diagnostic yield of an elaborate workup for comorbidities in a real-life HFpEF outpatient populationSanne G J Mourmans, Anouk Achten, Jerremy Weerts, et al.
Cardiovascular Diabetology|April 5, 2025
Temporal prevalence and prognostic impact of diabetes mellitus and albuminuria in heart failure with preserved ejection fractionNousjka P A Vranken, Xinyu Li, Heleen Bouman, et al.
Annals of Medicine|October 26, 2024
Diversity of heart failure phenotypes in transthyretin amyloid cardiomyopathy. More than just heart failure with preserved ejection fractionAnouk Achten, Steven A Muller, Sandra Sanders-van Wijk, et al.
Cardiovascular Diabetology|April 25, 2025
The effect of empagliflozin on peripheral microvascular dysfunction in patients with heart failure with preserved ejection fractionSanne G J Mourmans, Anouk Achten, Raquel Hermans, et al.
Pageof 2